J. De-leon, Pharmacogenomics: The Promise of Personalized Medicine for CNS Disorders, Neuropsychopharmacology, vol.320, issue.1, pp.159-172, 2009.
DOI : 10.1038/npp.2008.147

S. Porcelli, A. Drago, C. Fabbri, S. Gibiino, R. Calati et al., Pharmacogenetics of antidepressant response, Journal of Psychiatry & Neuroscience, vol.36, issue.2, pp.87-113, 2011.
DOI : 10.1503/jpn.100059

K. Pajer, B. Andrus, W. Gardner, L. A. Strange, B. Campo et al., Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression, Translational Psychiatry, vol.54, issue.4, p.101, 2012.
DOI : 10.1038/tp.2012.26

A. Niculescu and H. Le-niculescu, Convergent Functional Genomics: what we have learned and can learn about genes, pathways, and mechanisms, Neuropsychopharmacology, vol.141, issue.1, pp.355-356, 2010.
DOI : 10.1038/sj.mp.4001547
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055434

F. Mamdani, M. Berlim, M. Beaulieu, and G. Turecki, Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder, The World Journal of Biological Psychiatry, vol.34, issue.2, pp.135-144
DOI : 10.1042/BST0340761

R. Belzeaux, C. Formisano-treziny, A. Loundou, L. Boyer, J. Gabert et al., Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression, Journal of Psychiatric Research, vol.44, issue.16
DOI : 10.1016/j.jpsychires.2010.04.011

S. Spijker, J. Van-zanten, D. Jong, S. Penninx, B. Van-dyck et al., Stimulated Gene Expression Profiles as a Blood Marker of Major Depressive Disorder, Biological Psychiatry, vol.68, issue.2, pp.179-186, 2010.
DOI : 10.1016/j.biopsych.2010.03.017

F. Mamdani, M. Berlim, M. Beaulieu, A. Labbe, C. Merette et al., Gene expression biomarkers of response to citalopram treatment in major depressive disorder, Translational Psychiatry, vol.18, issue.6, p.13, 2011.
DOI : 10.1038/tp.2011.12

Z. Yi, Z. Li, S. Yu, C. Yuan, W. Hong et al., Blood-Based Gene Expression Profiles Models for Classification of Subsyndromal Symptomatic Depression and Major Depressive Disorder, PLoS ONE, vol.50, issue.2, p.31283
DOI : 10.1371/journal.pone.0031283.t005

K. Munkholm, M. Vinberg, M. Berk, and L. Kessing, State-related alterations of gene expression in bipolar disorder: a systematic review, Bipolar Disorders, vol.45, issue.7, pp.684-696
DOI : 10.1111/bdi.12005

R. Belzeaux, A. Bergon, V. Jeanjean, B. Loriod, C. Formisano-treziny et al., Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode, Translational Psychiatry, vol.101, issue.11, p.185, 2012.
DOI : 10.1007/s11920-010-0160-4
URL : http://doi.org/10.1038/tp.2012.112

J. Ruijter, M. Pfaffl, S. Zhao, A. Spiess, G. Boggy et al., Evaluation of qPCR curve analysis methods for reliable biomarker discovery: Bias, resolution, precision, and implications, Methods, vol.59, issue.1, pp.32-46, 2013.
DOI : 10.1016/j.ymeth.2012.08.011

A. Cattaneo, M. Gennarelli, R. Uher, G. Breen, A. Farmer et al., Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets', Neuropsychopharmacology, vol.2013, issue.383, pp.377-385

C. Tsao, Y. Lin, C. Chen, C. Bai, and S. Wu, Cytokines and serotonin transporter in patients with major depression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.30, issue.5, pp.899-905, 2006.
DOI : 10.1016/j.pnpbp.2006.01.029

J. Iga, S. Ueno, K. Yamauchi, I. Motoki, S. Tayoshi et al., Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine, Neuroscience Letters, vol.389, issue.1, pp.12-16, 2005.
DOI : 10.1016/j.neulet.2005.06.048

B. Alexander, J. Warner-schmidt, T. Eriksson, C. Tamminga, M. Arango-lievano et al., Reversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus Accumbens, Science Translational Medicine, vol.2, issue.54, pp.54-76, 2010.
DOI : 10.1126/scitranslmed.3001079

L. Zhang, T. Su, K. Choi, W. Maree, C. Li et al., P11 (S100A10) as a potential biomarker of psychiatric patients at risk of suicide, Journal of Psychiatric Research, vol.45, issue.4, pp.11435-441, 2011.
DOI : 10.1016/j.jpsychires.2010.08.012

P. Melas, M. Rogdaki, A. Lennartsson, K. Bjork, H. Qi et al., Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression, The International Journal of Neuropsychopharmacology, vol.15, issue.05, pp.669-679
DOI : 10.1017/S1461145711000940

M. Wong, C. Dong, V. Andreev, M. Arcos-burgos, and J. Licinio, Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors, Molecular Psychiatry, vol.103, issue.6, pp.624-633
DOI : 10.1016/j.jsbmb.2007.03.037

J. Iga, S. Ueno, K. Yamauchi, S. Numata, I. Motoki et al., Gene expression and association analysis of LIM (PDLIM5) in major depression, Neuroscience Letters, vol.400, issue.3, pp.400203-207, 2006.
DOI : 10.1016/j.neulet.2006.02.044

Y. Dowlati, N. Herrmann, W. Swardfager, H. Liu, L. Sham et al., A Meta-Analysis of Cytokines in Major Depression, Biological Psychiatry, vol.67, issue.5, pp.446-457, 2010.
DOI : 10.1016/j.biopsych.2009.09.033

R. Spitzer, J. Williams, and M. Gibbon, Structured clinical interview for DSM-III-R, patient edition/non-patient edition, 1990.

M. Begemann, D. Sargin, M. Rossner, C. Bartels, F. Theis et al., Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches, Mol Med, vol.14, pp.9-10546, 2008.

S. Gibney and H. Drexhage, Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders, Journal of Neuroimmune Pharmacology, vol.35, issue.4, pp.900-920
DOI : 10.1007/s11481-013-9462-8

R. Dantzer, O. Connor, J. Freund, G. Johnson, R. Kelley et al., From inflammation to sickness and depression: when the immune system subjugates the brain, Nature Reviews Neuroscience, vol.17, issue.1, pp.46-56, 2008.
DOI : 10.1038/nrn2297

R. Dantzer, O. Connor, J. Lawson, M. Kelley, and K. , Inflammation-associated depression: From serotonin to kynurenine, Psychoneuroendocrinology, vol.36, issue.3, pp.426-436, 2011.
DOI : 10.1016/j.psyneuen.2010.09.012
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053088

A. Miller, E. Haroon, C. Raison, and J. Felger, CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS, Depression and Anxiety, vol.23, issue.2, pp.297-306
DOI : 10.1002/da.22084

J. Warner-schmidt, K. Vanover, E. Chen, J. Marshall, and P. Greengard, Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans, Proceedings of the National Academy of Sciences, vol.108, issue.22, pp.9262-9267, 2011.
DOI : 10.1073/pnas.1104836108

E. Sibille and D. Lewis, SERT-ainly Involved in Depression, But When?, American Journal of Psychiatry, vol.163, issue.1, pp.8-11, 2006.
DOI : 10.1176/appi.ajp.163.1.8
URL : http://doi.org/10.1176/appi.ajp.163.1.8

A. Menke, J. Arloth, B. Putz, P. Weber, T. Klengel et al., Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients, Neuropsychopharmacology, vol.2012, issue.6, pp.371455-1464

A. Menke, T. Klengel, J. Rubel, T. Bruckl, H. Pfister et al., Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression, Genes, Brain and Behavior, vol.13, issue.Suppl. 1, pp.289-296
DOI : 10.1111/gbb.12026